Efficacy and Safety of 0.25% Timolol Gel in Healing Surgical Open Wounds
Status:
Active, not recruiting
Trial end date:
2021-06-30
Target enrollment:
Participant gender:
Summary
The use of topical beta-blockers, such as 0.25% timolol, in promoting wound healing is
currently emerging in the academic literature. The investigators will enroll 114 patients who
have their skin cancer surgically removed resulting in open surgical wounds less or equal to
1.5 cm. The objective of this randomized safety study is to determine the safety and efficacy
of 0.25% timolol in promoting wound healing in open surgical wounds less or equal to 1.5 cm.